The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available. METHODS: We reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models. RESULTS: Across all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55-64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09-2.24), followed by effects on both stroke subtypes (1.66; 1.39-1.98 for hemorrhagic stroke and 1.63; 1.57-1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29-1.61) for IHD and 1.20 (1.15-1.25) for ischemic stroke. The RRs for 5 kg/m(2) higher BMI for ages 55-64 ranged from 2.32 (2.04-2.63) for diabetes, to 1.44 (1.40-1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08-1.29) for IHD and 1.14 (1.01-1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs. CONCLUSION: Our results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the risk of CVD increases continuously with rising fasting plasma glucose levels, even before reaching levels sufficient for a diabetes diagnosis [5].”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citation(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“For BMI and FPG, confounding remains a concern as evidence from randomized trials of disease outcomes is either very limited for practical reasons (BMI) or provides mixed results (FPG) [49–52].”
BackgroundBariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800 · cited 14×
“Metabolic risk factors We compared and pooled RRs for the effects of key metabolic risk factors: SBP, TC, FPG, and adiposity measured by BMI, from major global pooling projects.”
BackgroundInfluentialCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Research works printed but not linked: 2
- James WPT, Jackson-Leach R, Ni Mhurchu C, Kalamara E, Shayeghi M, <etal>et al</etal>.. (2004) Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
- Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, <etal>et al</etal>.. (2004) High Blood Pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationHeart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Self-citationHeart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Cohen, A. J., Brauer, M., Burnett, R., Anderson, H. R., Frostad, J., Estep, K., Balakrishnan, K., Brunekreef, B., Dandona, L., Dandona, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30505-6 · Cited by 6,583
Afshin, A., Sur, P. J., Fay, K. A., Cornaby, L., Ferrara, G., Salama, J. S., Mullany, E. C., Abate, K. H., Abbafati, C., Abebe, Z., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30041-8 · Cited by 5,811
Self-citationStanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32225-6 · Cited by 4,943
Self-citationChooi, Y. C., Ding, C., & Magkos, F. (2019) · Metabolism · doi:10.1016/j.metabol.2018.09.005 · Cited by 2,737
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., et al. (2017) · JAMA · doi:10.1001/jama.2016.19043 · Cited by 2,381
Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0728-6 · Cited by 2,312
“Adults with diabetes historically have a higher prevalence rate of CVD than adults without diabetes [4], and the risk of CVD increases continuously with rising fasting plasma glucose levels, even before reaching levels sufficient for a diabetes diagnosis [5].”
Adipose tissue inflammation and metabolic dysfunction in obesity
Kawai, T., Autieri, M. V., & Scalia, R. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2020 · Cited by 1,947
Burnett, R. T., Pope, C. A., Ezzati, M., Olives, C., Lim, S. S., Mehta, S., Shin, H. H., Singh, G., Hubbell, B., Brauer, M., et al. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307049 · Cited by 1,901
“The slope of the regression line was estimated from a meta-analysis of several risk volume 122 | number 4 | April 2014 • Environmental Health Perspectives factors (Singh et al. 2013).”
Self-citationZhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00559-8 · Cited by 1,521
Self-citationHerrington, W., Lacey, B., Sherliker, P., Armitage, J., & Lewington, S. (2016) · Circulation Research · doi:10.1161/circresaha.115.307611 · Cited by 1,469
Self-citationMicha, R., Peñalvo, J. L., Cudhea, F., Imamura, F., Rehm, C. D., & Mozaffarian, D. (2017) · JAMA · doi:10.1001/jama.2017.0947 · Cited by 1,218
Self-citationGlobal Sodium Consumption and Death from Cardiovascular Causes
Mozaffarian, D., Fahimi, S., Singh, G. M., Micha, R., Khatibzadeh, S., Engell, R. E., Lim, S., Danaei, G., Ezzati, M., & Powles, J. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304127 · Cited by 1,218
Self-citationThe obesity transition: stages of the global epidemic
Jaacks, L. M., Vandevijvere, S., Pan, A., McGowan, C. J., Wallace, C., Imamura, F., Mozaffarian, D., Swinburn, B., & Ezzati, M. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30026-9 · Cited by 1,193
Self-citationBoutari, C., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155217 · Cited by 1,068
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Springmann, M., Wiebe, K., Mason-D'Croz, D., Sulser, T. B., Rayner, M., & Scarborough, P. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30206-7 · Cited by 952
(2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70102-0 · Cited by 800
Rising rural body-mass index is the main driver of the global obesity epidemic in adults
NCD Risk Factor Collaboration (NCD-RisC), Bixby, H., Bentham, J., Zhou, B., Di Cesare, M., Paciorek, C. J., Bennett, J. E., Taddei, C., Stevens, G. A., Rodriguez-Martinez, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1171-x · Cited by 735
Self-citationAdipokine dysregulation and adipose tissue inflammation in human obesity
Unamuno, X., Gómez‐Ambrosi, J., Rodríguez, A., Becerril, S., Frühbeck, G., & Catalán, V. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12997 · Cited by 610
Springmann, M., Spajic, L., Clark, M. A., Poore, J., Herforth, A., Webb, P., Rayner, M., & Scarborough, P. (2020) · BMJ · doi:10.1136/bmj.m2322 · Cited by 520
for the ADVANCE Collaborative group, Zoungas, S., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S., Heller, S., Marre, M., Patel, A., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3369-7 · Cited by 497
“Our findings are also consistent with a recent pooled analysis, which reported that the proportional effects of vascular risk factors including systolic blood pressure and total cholesterol declined with age, such that the greatest relative risks were observed in the younger individuals aged 55–64 years [18].”
ResultSelf-citationMicha, R., Shulkin, M. L., Peñalvo, J. L., Khatibzadeh, S., Singh, G. M., Rao, M., Fahimi, S., Powles, J., & Mozaffarian, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175149 · Cited by 476
Self-citationHogan, D. R., Stevens, G. A., Hosseinpoor, A. R., & Boerma, T. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30472-2 · Cited by 444
Self-citationKontis, V., Mathers, C. D., Rehm, J., Stevens, G. A., Shield, K. D., Bonita, R., Riley, L. M., Poznyak, V., Beaglehole, R., & Ezzati, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60616-4 · Cited by 418
Self-citationType-2 diabetes mellitus and cardiovascular disease
Henning, R. J. (2018) · Future Cardiology · doi:10.2217/fca-2018-0045 · Cited by 398
Singh, G. M., Micha, R., Khatibzadeh, S., Lim, S., Ezzati, M., & Mozaffarian, D. (2015) · Circulation · doi:10.1161/circulationaha.114.010636 · Cited by 390
Self-citationEffective weight control via an implanted self-powered vagus nerve stimulation device
Yao, G., Kang, L., Li, J., Long, Y., Wei, H., Ferreira, C. A., Jeffery, J. J., Lin, Y., Cai, W., & Wang, X. (2018) · Nature Communications · doi:10.1038/s41467-018-07764-z · Cited by 348
Contributions of risk factors and medical care to cardiovascular mortality trends
Ezzati, M., Obermeyer, Z., Tzoulaki, I., Mayosi, B. M., Elliott, P., & Leon, D. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.82 · Cited by 338
Self-citationPearson-Stuttard, J., Bennett, J., Cheng, Y. J., Vamos, E. P., Cross, A. J., Ezzati, M., & Gregg, E. W. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30431-9 · Cited by 335
Self-citationObesity Stigma: Causes, Consequences, and Potential Solutions
Westbury, S., Oyebode, O., van Rens, T., & Barber, T. M. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00495-3 · Cited by 317
Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine
Nimptsch, K., Konigorski, S., & Pischon, T. (2019) · Metabolism · doi:10.1016/j.metabol.2018.12.006 · Cited by 314
Zhang, M., Wang, B., Liu, Y., Sun, X., Luo, X., Wang, C., Li, L., Zhang, L., Ren, Y., Zhao, Y., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0514-x · Cited by 305
“Adiposity is the most important modifiable risk factor for T2DM [7, 8].”
BackgroundRepositioning of the global epicentre of non-optimal cholesterol
NCD Risk Factor Collaboration (NCD-RisC), Taddei, C., Zhou, B., Bixby, H., Carrillo-Larco, R. M., Danaei, G., Jackson, R. T., Farzadfar, F., Sophiea, M. K., Di Cesare, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2338-1 · Cited by 298
Self-citationObesity and cancer: An update of the global impact
Arnold, M., Leitzmann, M., Freisling, H., Bray, F., Romieu, I., Renehan, A., & Soerjomataram, I. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.01.003 · Cited by 300
Pearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30150-5 · Cited by 307
Self-citationRetractedYun, J.-S., & Ko, S.-H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154838 · Cited by 292
Hajifathalian, K., Ueda, P., Lu, Y., Woodward, M., Ahmadvand, A., Aguilar-Salinas, C. A., Azizi, F., Cifkova, R., Di Cesare, M., Eriksen, L., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00081-9 · Cited by 287
Self-citationEpigenetic changes during aging and their reprogramming potential
Kane, A. E., & Sinclair, D. A. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1570075 · Cited by 283
“This relocalization results in transcription of hundreds of genes including changes that are characteristic of aging such as expression of LINE1 elements and developmental genes such as Hoxa9 and Wnt (Logan and Nusse 2004; Clevers 2006; Brack et al. 2007; Oberdoerffer et al. 2008; Singh et al. 2013).”
BackgroundType 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies
Pearson-Stuttard, J., Papadimitriou, N., Markozannes, G., Cividini, S., Kakourou, A., Gill, D., Rizos, E. C., Monori, G., Ward, H. A., Kyrgiou, M., et al. (2021) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1245 · Cited by 267
“Compelling evidence for a causal link between type 2 diabetes mellitus (T2DM) and renal disease (2), coronary heart disease (3) and stroke (2) has led to the development of targeted prevention approaches (4).”
BackgroundMacrophages, Chronic Inflammation, and Insulin Resistance
Li, H., Meng, Y., He, S., Tan, X., Zhang, Y., Zhang, X., Wang, L., & Zheng, W. (2022) · Cells · doi:10.3390/cells11193001 · Cited by 264
“Obesity has a significant impact on the physiological functions of the human body and increases the risk of many metabolic diseases, including type 2 diabetes (T2D) [4,5], non-alcoholic fatty liver [6–8], atherosclerosis [9,10], cardiovascular disease [5], musculoskeletal diseases [11], and cancer [12–14].”
BackgroundGenco, R. J., Graziani, F., & Hasturk, H. (2020) · Periodontology 2000 · doi:10.1111/prd.12271 · Cited by 262
Pearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30366-2 · Cited by 265
Self-citationRetractedAshrafian, F., Shahriary, A., Behrouzi, A., Moradi, H. R., Keshavarz Azizi Raftar, S., Lari, A., Hadifar, S., Yaghoubfar, R., Ahmadi Badi, S., Khatami, S., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02155 · Cited by 254
Safiri, S., Karamzad, N., Kaufman, J. S., Bell, A. W., Nejadghaderi, S. A., Sullman, M. J. M., Moradi-Lakeh, M., Collins, G., & Kolahi, A.-A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838027 · Cited by 252
Tzoulaki, I., Elliott, P., Kontis, V., & Ezzati, M. (2016) · Circulation · doi:10.1161/circulationaha.115.008718 · Cited by 236
Self-citationDietary Sodium and Cardiovascular Disease Risk — Measurement Matters
Cogswell, M. E., Mugavero, K., Bowman, B. A., & Frieden, T. R. (2016) · New England Journal of Medicine · doi:10.1056/nejmsb1607161 · Cited by 211
“…with the linear dose–response effect of sodium intake on blood pressure and of blood pressure on the risk of cardiovascular disease or death, 3–9 analyses of general population cohort studies 6,38–40 or of specific groups, such as patients with chronic kidney disease, 41 support a positive…”
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Klil-Drori, A. J., Azoulay, L., & Pollak, M. N. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.120 · Cited by 210
Leiria, L. O., Wang, C.-H., Lynes, M. D., Yang, K., Shamsi, F., Sato, M., Sugimoto, S., Chen, E. Y., Bussberg, V., Narain, N. R., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.001 · Cited by 204
“Several epidemiologic studies have identified high body mass index (BMI) as a risk factor for many chronic diseases, including cardiovascular disease and diabetes mellitus (Singh et al., 2013; Roberto et al., 2015), illustrating the urgency for identifying novel molecular targets and therapeutic strategies to treat th…”
BackgroundIncident type 2 diabetes attributable to suboptimal diet in 184 countries
O’Hearn, M., Lara-Castor, L., Cudhea, F., Miller, V., Reedy, J., Shi, P., Zhang, J., Wong, J. B., Economos, C. D., Micha, R., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02278-8 · Cited by 196
Self-citationChristensen, P., Meinert Larsen, T., Westerterp‐Plantenga, M., Macdonald, I., Martinez, J. A., Handjiev, S., Poppitt, S., Hansen, S., Ritz, C., Astrup, A., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13466 · Cited by 188
“Conversely, the prevalence of impaired glucose tolerance (IGT), which is indicative of skeletal muscle IR, has been reported to be higher in women than in men in almost all age groups.(16) In this study, we aimed to compare the effects of an 8-week LEDinduced weight loss on metabolic outcomes in a large group of men a…”
BackgroundGlobal Improvement in Dietary Quality Could Lead to Substantial Reduction in Premature Death
Wang, D. D., Li, Y., Afshin, A., Springmann, M., Mozaffarian, D., Stampfer, M. J., Hu, F. B., Murray, C. J. L., & Willett, W. C. (2019) · The Journal of Nutrition · doi:10.1093/jn/nxz010 · Cited by 183
“8 y), which could lead to conservative estimates of the PAFs and preventable premature deaths because relative risks for modifiable variables generally decline with age (71).”
BackgroundSelf-citationTrends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018
O’Hearn, M., Lauren, B. N., Wong, J. B., Kim, D. D., & Mozaffarian, D. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.04.046 · Cited by 175
Self-citationAgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity
Vohra, M. S., Benchoula, K., Serpell, C. J., & Hwa, W. E. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174611 · Cited by 181
Wang, Q., Afshin, A., Yakoob, M. Y., Singh, G. M., Rehm, C. D., Khatibzadeh, S., Micha, R., Shi, P., Mozaffarian, D., the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE), et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002891 · Cited by 162
Self-citationSiam, N. H., Snigdha, N. N., Tabasumma, N., & Parvin, I. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2512436 · Cited by 214
“The risk of CVD increases proportionally with mounting blood sugar levels, even before blood glucose reaches diabetic thresholds [ 9,10].”
Duncan, M. S., Vasan, R. S., & Xanthakis, V. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011433 · Cited by 156
“A few studies have examined the association between circulating lipid levels over time and the risk of ASCVD or allcause mortality but these investigations either used mean or time-averaged values of lipids during follow-up,(12,13) or only examined the impact of a single lipid species.(14,15) In addition, investigator…”
BackgroundLiu, M., Liu, S.-W., Wang, L.-J., Bai, Y.-M., Zeng, X.-Y., Guo, H.-B., Liu, Y.-N., Jiang, Y.-Y., Dong, W.-L., He, G.-X., et al. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.08.008 · Cited by 156
Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database
Allott, E. H., Howard, L. E., Cooperberg, M. R., Kane, C. J., Aronson, W. J., Terris, M. K., Amling, C. L., & Freedland, S. J. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0458 · Cited by 161
“Given the established link between abnormal serum lipid levels and increased risk of death from causes other than prostate cancer (27), we also conducted secondary analyses using a Cox propor-”
Ueda, P., Woodward, M., Lu, Y., Hajifathalian, K., Al‐Wotayan, R., Aguilar-Salinas, C. A., Ahmadvand, A., Azizi, F., Bentham, J., Cífková, R., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30015-3 · Cited by 169
Self-citationLong term exposure to air pollution and mortality in an elderly cohort in Hong Kong
Yang, Y., Tang, R., Qiu, H., Lai, P., Wong, P. P. Y., Thach, T., Allen, R. W., Brauer, M. D., Tian, L., & Barratt, B. (2018) · Environment International · doi:10.1016/j.envint.2018.04.034 · Cited by 151
Bennett, J. E., Tamura-Wicks, H., Parks, R. M., Burnett, R. T., Pope, C. A., Bechle, M. J., Marshall, J. D., Danaei, G., & Ezzati, M. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002856 · Cited by 147
Self-citationArmstrong, A., Jungbluth Rodriguez, K., Sabag, A., Mavros, Y., Parker, H. M., Keating, S. E., & Johnson, N. A. (2022) · Obesity Reviews · doi:10.1111/obr.13446 · Cited by 142
Social Risk Profile and Cardiovascular‐Kidney‐Metabolic Syndrome in US Adults
Li, J., Lei, L., Wang, W., Ding, W., Yu, Y., Pu, B., Peng, Y., Li, Y., Zhang, L., & Guo, Y. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034996 · Cited by 160
Use of Urine Biomarkers to Assess Sodium Intake: Challenges and Opportunities
Cogswell, M. E., Maalouf, J., Elliott, P., Loria, C. M., Patel, S., & Bowman, B. A. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034322 · Cited by 156
“Excess sodium intake increases the risk for high blood pressure, and high blood pressure, or hypertension, is a leading risk factor for cardiovascular disease (2, 52, 55, 132).”
Ricci, C., Gaeta, M., Rausa, E., Asti, E., Bandera, F., & Bonavina, L. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1442-4 · Cited by 157
“uted with being responsible for 44 % of cases of diabetes, 23 % of ischemic heart diseases and up to 41 % of some cancers [7], and accounts for about 20 % of the excess death rate in the USA [8].”
BackgroundTakizawa, R., Danese, A., Maughan, B., & Arseneault, L. (2015) · Psychological Medicine · doi:10.1017/s0033291715000653 · Cited by 134
Adler, A. J., Prabhakaran, D., Bovet, P., Kazi, D. S., Mancia, G., Mungal-Singh, V., & Poulter, N. (2015) · Global Heart · doi:10.1016/j.gheart.2015.04.006 · Cited by 132
Advances in Healthcare Electronics Enabled by Triboelectric Nanogenerators
Chen, X., Xie, X., Liu, Y., Zhao, C., Wen, M., & Wen, Z. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004673 · Cited by 133
Association between the price of ultra-processed foods and obesity in Brazil
dos Passos, C. M., Maia, E. G., Levy, R. B., Martins, A. P. B., & Claro, R. M. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.12.011 · Cited by 128
“Obesity is characterized both as a disease and as a risk factor for other noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and certain types of cancer [4].”
BackgroundAfshin, A., Micha, R., Khatibzadeh, S., Fahimi, S., Shi, P., Powles, J. W., Singh, G. M., Yakoob, M. Y., Abdollahi, M., Al-Hooti, S., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006385 · Cited by 145
“For each risk factor-disease pair, we used the same RR for men and women and consistent agepatterns of RRs.(23) Effect modification by other factors (eg, race, prevalent disease) was also evaluated and incorporated in the analysis where applicable.”
MethodInfluentialSelf-citationGroup‐based trajectory modelling for BMI trajectories in childhood: A systematic review
Mattsson, M., Maher, G. M., Boland, F., Fitzgerald, A. P., Murray, D. M., & Biesma, R. (2019) · Obesity Reviews · doi:10.1111/obr.12842 · Cited by 121
Lara-Castor, L., O’Hearn, M., Cudhea, F., Miller, V., Shi, P., Zhang, J., Sharib, J. R., Cash, S. B., Barquera, S., Micha, R., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03345-4 · Cited by 152
“…ischemic heart disease and ischemic stroke adjusted for BMI 2,68–70 , and of weight gain on T2D 15 , ischemic heart disease 16 and ischemic stroke 15 from previous meta-analyses and pooled analyses of prospective cohorts, as well as linear, BMI-stratified effects of SSBs on weight gain or loss…”
InfluentialSelf-citationPatel, S. A., Ali, M. K., Alam, D. S., Yan, L. L., Levitt, N. S., Bernabé‐Ortiz, A., Checkley, W., Wu, Y., Irazola, V. E., Gutiérrez, L., et al. (2016) · Global Heart · doi:10.1016/j.gheart.2016.01.003 · Cited by 138
“For example, in a large study of Asians and Europeans, the associations between BMI and incident diabetes were higher at younger relative to older ages [30].”
Self-citationObesity, overweight and risk for cardiovascular disease and mortality in young women
Dikaiou, P., Bjorck, L. M., Adiels, M., Lundberg, C. E., Mandalenakis, Z., Manhem, K., & Rosengren, A. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320908983 · Cited by 140
Marklund, M., Singh, G. M., Greer, R. C., Cudhea, F., Matsushita, K., Micha, R., Brady, T. M., Zhao, D., Huang, L., Tian, M., et al. (2020) · BMJ · doi:10.1136/bmj.m824 · Cited by 125
“We used estimates of the SBP effect on CVD outcomes and incident CKD from the Global Burden of Disease (GBD) Study,(6) 8 except for hypertensive heart disease for which we used estimates from our previous meta-analysis.(9) The PIF for each CVD outcome (o) is defined as”
MethodSelf-citationCacau, L. T., Benseñor, I. M., Goulart, A. C., Cardoso, L. O., Lotufo, P. A., Moreno, L. A., & Marchioni, D. M. L. (2021) · Nutrients · doi:10.3390/nu13113691 · Cited by 127
Large-for-gestational-age phenotypes and obesity risk in adulthood: a study of 195,936 women
Derraik, J. G. B., Maessen, S. E., Gibbins, J. D., Cutfield, W. S., Lundgren, M., & Ahlsson, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-58827-5 · Cited by 129
Healthy excursions outside the thermal comfort zone
van Marken Lichtenbelt, W., Hanssen, M., Pallubinsky, H., Kingma, B., & Schellen, L. (2017) · Building Research & Information · doi:10.1080/09613218.2017.1307647 · Cited by 109
“The metabolic syndrome is one of the most widespread adverse health conditions worldwide and is characterized by obesity, accompanied by a high risk of developing type 2 diabetes, cardiovascular diseases and even certain forms of cancer (Singh et al., 2013).”
BackgroundReward-Induced Eating: Therapeutic Approaches to Addressing Food Cravings
Rebello, C. J., & Greenway, F. L. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0414-6 · Cited by 105
“Current obesity guidelines suggest that sustained weight loss of just 3–5% achieved through lifestyle interventions can result in clinically significant positive metabolic outcomes [2].”
BackgroundPotential Impact of Time Trend of Life-Style Factors on Cardiovascular Disease Burden in China
Li, Y., Wang, D. D., Ley, S. H., Howard, A. G., He, Y., Lu, Y., Danaei, G., & Hu, F. B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.011 · Cited by 111
“, PLoS One 2013 (32) High blood glucose Fasting blood glucose 4.”
BackgroundSelf-citationKontis, V., Cobb, L. K., Mathers, C. D., Frieden, T. R., Ezzati, M., & Danaei, G. (2019) · Circulation · doi:10.1161/circulationaha.118.038160 · Cited by 115
Self-citationThe Role of Obesity-Induced Perivascular Adipose Tissue (PVAT) Dysfunction in Vascular Homeostasis
Stanek, A., Brożyna-Tkaczyk, K., & Myśliński, W. (2021) · Nutrients · doi:10.3390/nu13113843 · Cited by 119
“Obesity is a risk factor for developing many disorders such as diabetes mellitus, hypertension, cardiovascular events, obstructive sleep apnea syndrome, certain cancers, and musculoskeletal diseases [5].”
BackgroundPrevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study)
Dedov, I. I., Shestakova, M. V., Benedetti, M. M., Simon, D., Pakhomov, I., & Galstyan, G. R. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.02.010 · Cited by 120
“[14] Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, et al.”
BackgroundA major mechanism for immunomodulation: Dietary fibres and acid metabolites
Xie, L., Alam, J., Marques, F. Z., & Mackay, C. R. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101737 · Cited by 110
Kızılay, F., Gali, H. E., & Şerefoğlu, E. C. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2016.07.002 · Cited by 106
Pollinator Deficits, Food Consumption, and Consequences for Human Health: A Modeling Study
Smith, M. R., Mueller, N. D., Springmann, M., Sulser, T. B., Garibaldi, L. A., Gerber, J., Wiebe, K., & Myers, S. S. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10947 · Cited by 116
Felisbino-Mendes, M. S., Cousin, E., Malta, D. C., Machado, Í. E., Ribeiro, A. L. P., Duncan, B. B., Schmidt, M. I., Silva, D. A. S., Glenn, S., Afshin, A., et al. (2020) · Population Health Metrics · doi:10.1186/s12963-020-00219-y · Cited by 117
“A high body mass index (BMI) is one of the major causes of several diseases worldwide, constituting an important risk factor for cardiovascular diseases (CVDs) [4], type 2 diabetes mellitus [4], and neoplasms [5], among others.”
BackgroundLow-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk
Naude, C. E., Brand, A., Schoonees, A., Nguyen, K. A., Chaplin, M., & Volmink, J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013334.pub2 · Cited by 91
Kundu, J., & Kundu, S. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2021.100937 · Cited by 93
Indoor thermal environment and human health: A systematic review
Liu, G., Chen, H., Yuan, Y., & Song, C. (2023) · Renewable and Sustainable Energy Reviews · doi:10.1016/j.rser.2023.114164 · Cited by 100
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 111
“The dyslipidemia process can induce CVDs, such as hypertension, myocardial infarction, and stroke [57,58].”
BackgroundRecchia, F., Leung, C. K., Yu, A. P., Leung, W., Yu, D. J., Fong, D., Montero, D., Lee, C., Wong, S. H., & Siu, P. M. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106304 · Cited by 102
Odden, M. C., Shlipak, M. G., Whitson, H. E., Katz, R., Kearney, P. M., defilippi, C., Shastri, S., Sarnak, M. J., Siscovick, D. S., Cushman, M., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.012 · Cited by 81
Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system)
Ostovar, A., Nabipour, I., Larijani, B. A., Heshmat, R., Darabi, H., Vahdat, K., Ravanipour, M., Mehrdad, N., Raeisi, A., Heidari, G., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009597 · Cited by 89
“Periodic and consistent monitoring of trends and the effects of these risk factors on disease burden is needed for prioritising prevention programmes.(9) In recent decades, cohort studies have played a major role in investigating the incidence and causes of common health outcomes.”
Background
Metadata
- Authors
- Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., Di Angelantonio, E., vander Hoorn, S., Lawes, C. M. M., Ali, M. K., Mozaffarian, D., Ezzati, M., Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC), (DECODE), D. E. C. A. O. D. C. I. E., Emerging Risk Factor Collaboration (ERFC), & Prospective Studies Collaboration (PSC)
- Affiliations
- Harvard University (US)
- Tehran University of Medical Sciences (IR)
- World Health Organization (CH)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- University of Helsinki (FI)
- University of Auckland (NZ)
- Emory University (US)
- Brigham and Women's Hospital (US)
- MRC Centre for Environment and Health (GB)
- Corresponding author
- Ezzati, Majid
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-30
- Volume
- 8
- Issue
- 7
- Pages
- e65174
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3728292
- OpenAlex
- W2122520859
- Cited by
- 772
- References
- 67
- Citations by year
- 2026: 29 · 2025: 64 · 2024: 84 · 2023: 87 · 2022: 103 · 2021: 86 · 2020: 85 · 2019: 66 · 2018: 43 · 2017: 49 · 2016: 41 · 2015: 18 · 2014: 16 · 2013: 1
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- World Health Organization
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/013/25942, RG/07/008/23674, RG/08/014/24067)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Medical Research Council (MR/K005901/1, MR/L003120/1)
- Economic and Social Research Council (ES/F02679X/1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK007703., T32DK007703)
- National Institute of Environmental Health Sciences (P30ES005605)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic risk factors, cardiovascular disease, diabetes mellitus, systolic blood pressure, total cholesterol, fasting blood glucose, body mass index, ischemic heart disease, hypertensive heart disease, stroke, sex differences, pooled cohort analysis, relative risk, effect modification by age
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk, Sex Factors, Body Mass Index, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.